Consolidated Statements Of Shareholders' Equity - USD ($) $ in Thousands	Common Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Loss, Net	Retained Earnings	Treasury Shares	Noncontrolling Interests	Total
Balance at beginning of period at Dec. 31, 2014	$ 5	$ 352,166	$ (83,007)	$ 118,817	$ (97,835)	$ (3,611)	$ 286,535
Ordinary Shares, shares outstanding, beginning balance at Dec. 31, 2014	44,562,000
Issuance of common shares for share-based compensation, net of forfeitures		1,107					1,107
Issuance of common shares for share-based compensation, net of forfeitures, shares	530,000
Repurchase of common shares					(4,731)		(4,731)
Repurchase of common shares, shares	(138,000)
Share-based compensation expense		19,306					19,306
Additional tax benefit related to share-based compensation		1,985					1,985
Unrealized gain on interest rate swap and foreign currency forward contracts, net of deferred income tax expense			6,058				6,058
Net income attributable to controlling interests				67,080			67,080
Net loss attributable to noncontrolling interest						(1,099)	(1,099)
Foreign currency translation adjustments, net of deferred income tax (benefit)			(11,177)			661	(10,516)
Additional investment in Cardtronics Mexico joint venture						4,068	4,068
Balance at end of period at Dec. 31, 2015	$ 5	374,564	(88,126)	185,897	(102,566)	19	369,793
Ordinary Shares, shares outstanding, ending balance at Dec. 31, 2015	44,954,000
Issuance of common shares for share-based compensation, net of forfeitures		450					450
Issuance of common shares for share-based compensation, net of forfeitures, shares	500,000
Repurchase of common shares					(3,959)		(3,959)
Repurchase of common shares, shares	(128,000)
Share-based compensation expense		21,430					21,430
Additional tax benefit related to share-based compensation		338					338
Unrealized gain on interest rate swap and foreign currency forward contracts, net of deferred income tax expense			15,990				15,990
Net income attributable to controlling interests				87,991			87,991
Net loss attributable to noncontrolling interest						(81)	(81)
Foreign currency translation adjustments, net of deferred income tax (benefit)			(34,999)			(18)	(35,017)
Change in common shares, treasury shares, and additional paid-in capital associated with the Redomicile Transaction	$ 448	(85,741)		(21,232)	$ 106,525
Balance at end of period at Dec. 31, 2016	$ 453	311,041	(107,135)	252,656		(80)	$ 456,935
Ordinary Shares, shares outstanding, ending balance at Dec. 31, 2016	45,326,000						45,326,430
Issuance of common shares for share-based compensation, net of forfeitures	$ 4	104					$ 108
Issuance of common shares for share-based compensation, net of forfeitures, shares	370,000
Share-based compensation expense		14,375					14,375
Tax payments related to share-based compensation		(8,580)					(8,580)
Unrealized gain on interest rate swap and foreign currency forward contracts, net of deferred income tax expense			17,029	(636)			16,393
Net income attributable to controlling interests				(145,350)			(145,350)
Net loss attributable to noncontrolling interest						(1)	(1)
Foreign currency translation adjustments, net of deferred income tax (benefit)			56,511			2	56,513
Balance at end of period at Dec. 31, 2017	$ 457	$ 316,940	$ (33,595)	$ 106,670		$ (79)	$ 390,393
Ordinary Shares, shares outstanding, ending balance at Dec. 31, 2017	45,696,000						45,696,338